EP Patent

EP2402003A2 — Diclofenac formulations and methods of use

Assigned to APR Applied Pharma Research SA · Expires 2012-01-04 · 14y expired

What this patent protects

The present invention relates to a pharmaceutical formulation comprising mannitol and diclofenac or a pharmaceutically acceptable salt thereof in a particulate form at a weight ratio of greater than about 1.5:1.

USPTO Abstract

The present invention relates to a pharmaceutical formulation comprising mannitol and diclofenac or a pharmaceutically acceptable salt thereof in a particulate form at a weight ratio of greater than about 1.5:1.

Drugs covered by this patent

Patent Metadata

Patent number
EP2402003A2
Jurisdiction
EP
Classification
—
Expires
2012-01-04
Drug substance claim
No
Drug product claim
No
Assignee
APR Applied Pharma Research SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.